Physician profile
Mark R Avon
NPI 1689711756
$3,817.94
in general payments reported to CMS, 2019-2025
40 companies · $674 in 2025
The $674 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $482 · 2020: $411 · 2021: $383 · 2022: $586 · 2023: $540 · 2024: $742 · 2025: $674.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,878 · Education: $77.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,878.29 |
| Education | $77.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $440.56 | 2019-2025 | Xyosted |
| Janssen Biotech, INC. | $361.73 | 2019-2025 | Erleada |
| Sumitomo Pharma America, INC. | $324.49 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $288.50 | 2019-2024 | Myrbetriq, Veozah |
| Pfizer INC. | $212.44 | 2019-2025 | |
| Abbvie INC. | $209.70 | 2020-2025 | Lupron Depot |
| Endo Pharmaceuticals INC. | $201.36 | 2019-2022 | |
| Myriad Genetic Laboratories, INC. | $178.03 | 2022-2025 | Prolaris |
| 180 Medical, INC. | $142.16 | 2019-2022 | |
| Rochester Medical Corporation | $113.48 | 2020 | |
| Boston Scientific Corporation | $113.43 | 2019-2024 | Rezum Generator |
| Laborie Medical Technologies Corp. | $106.32 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Myovant Sciences INC. | $105.39 | 2021-2022 | |
| Amgen INC. | $96.13 | 2020-2022 | |
| Ambu INC. | $90.24 | 2024-2025 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Avon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.